BioMarin Pharmaceutical, Inc. (BMRN)

Netty03 (< 20) Submitted: 12/17/07 3:02 AM : Start Price: $35.44 BMRN Score: -4.18

seems to be working

Report this Post Replies: 0 | Reply | Permalink

EdSenior (73.80) Submitted: 3/10/08 2:14 PM : Start Price: $32.43 BMRN Score: 7.62

Swimming against the tide here. Muddled market. Same with The Fed. Throwing out the baby with the Bath water on this one.

Report this Post Replies: 0 | Reply | Permalink

Jorgedig (20.72) Submitted: 12/28/07 11:42 AM : Start Price: $35.69 BMRN Score: -4.03

Like the focus on rareish enzyme disorders.

Report this Post Replies: 0 | Reply | Permalink

abacusdude (61.87) Submitted: 12/31/07 9:17 AM : Start Price: $35.57 BMRN Score: -4.19

$52 in a year.

Report this Post Replies: 0 | Reply | Permalink

DanWyns (28.23) Submitted: 1/03/08 3:42 PM : Start Price: $37.15 BMRN Score: -7.66

bought this in my real portfolio

Report this Post Replies: 0 | Reply | Permalink

captnhowdydodat (59.72) Submitted: 1/12/08 12:41 AM : Start Price: $39.45 BMRN Score: -12.23

Never heard of BRMN until I found this site, and at first I was skeptical because it seems that everyone is so bullish on it. I did my homework though and Kuvan is approved as of mid December. The drug is really expensive and the company is predictin...

Report this Post Replies: 0 | Reply | Permalink

bigsmooth (67.29) Submitted: 1/23/08 3:33 PM : Start Price: $37.36 BMRN Score: -13.28

I bought this stock in the $3 dollar range and have never looked back. It makes sense, great past successes will assure future input of money. They have little regulatory obstacles because they are an orphan drug company. Nothing stands in their w...

Report this Post Replies: 0 | Reply | Permalink

Parobek (40.70) Submitted: 2/08/08 8:41 PM : Start Price: $36.76 BMRN Score: -12.33

Week #2 - Friday: 'Stock Pick of the Day'

Report this Post Replies: 0 | Reply | Permalink

ecabiac (66.31) Submitted: 10/07/08 9:37 PM : Start Price: $22.89 BMRN Score: 3.93

P/E Ratio of 985.4 is over 47x industry.


May be over leveraged with 2.52 Debt/Equity and 11.1 Current.


Decent income indicates that this is likely a strong company that is simply overpriced at the moment.

Report this Post Replies: 0 | Reply | Permalink

Elektrawoman (65.04) Submitted: 2/27/08 5:57 PM : Start Price: $39.30 BMRN Score: -13.82

Enzyme deficiency has been linked to conditions like Autism and Alzheimers, this company seems to corner the market. I really like them!

Report this Post Replies: 0 | Reply | Permalink